BSW Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.62M | Sell |
10,424
-72
| -0.7% | -$15.5K | 0.29% | 53 |
|
|
2026
Q1 | $2.28M | Buy |
10,496
+169
| +2% | +$37.5K | 0.28% | 52 |
|
|
2025
Q4 | $2.36M | Sell |
10,327
-505
| -5% | -$115K | 0.28% | 52 |
|
|
2025
Q3 | $2.51M | Buy |
10,832
+1,130
| +12% | +$230K | 0.31% | 48 |
|
|
2025
Q2 | $1.8M | Sell |
9,702
-264
| -3% | -$49.1K | 0.25% | 56 |
|
|
2025
Q1 | $2.09M | Sell |
9,966
-1,509
| -13% | -$293K | 0.32% | 48 |
|
|
2024
Q4 | $2.04M | Buy |
11,475
+1,879
| +20% | +$345K | 0.3% | 48 |
|
|
2024
Q3 | $1.9M | Buy |
9,596
+586
| +7% | +$109K | 0.28% | 49 |
|
|
2024
Q2 | $1.55M | Buy |
9,010
+93
| +1% | +$15.4K | 0.25% | 50 |
|
|
2024
Q1 | $1.62M | Sell |
8,917
-320
| -3% | -$55.1K | 0.28% | 53 |
|
|
2023
Q4 | $1.43M | Sell |
9,237
-122
| -1% | -$17.8K | 0.28% | 47 |
|
|
2023
Q3 | $1.39M | Buy |
9,359
+120
| +1% | +$17.6K | 0.31% | 44 |
|
|
2023
Q2 | $1.24M | Sell |
9,239
-690
| -7% | -$101K | 0.26% | 52 |
|
|
2023
Q1 | $1.58M | Sell |
9,929
-87
| -0.9% | -$13.3K | 0.32% | 45 |
|
|
2022
Q4 | $1.62M | Buy |
10,016
+112
| +1% | +$17.2K | 0.35% | 44 |
|
|
2022
Q3 | $1.33M | Buy |
9,904
+49
| +0.5% | +$7.03K | 0.33% | 35 |
|
|
2022
Q2 | $1.51M | Buy |
9,855
+345
| +4% | +$52.7K | 0.36% | 35 |
|
|
2022
Q1 | $1.54M | Buy |
9,510
+825
| +9% | +$120K | 0.39% | 35 |
|
|
2021
Q4 | $1.18M | Buy |
8,685
+2,574
| +42% | +$304K | 0.3% | 51 |
|
|
2021
Q3 | $659K | Sell |
6,111
-561
| -8% | -$64.1K | 0.18% | 72 |
|
|
2021
Q2 | $751K | Sell |
6,672
-462
| -6% | -$52K | 0.21% | 66 |
|
|
2021
Q1 | $772K | Sell |
7,134
-1,531
| -18% | -$164K | 0.22% | 59 |
|
|
2020
Q4 | $928K | Buy |
8,665
+808
| +10% | +$77.6K | 0.29% | 42 |
|
|
2020
Q3 | $688K | Sell |
7,857
-219
| -3% | -$20.6K | 0.26% | 46 |
|
|
2020
Q2 | $793K | Buy |
8,076
+924
| +13% | +$81.4K | 0.27% | 43 |
|
|
2020
Q1 | $545K | Buy |
7,152
+1,365
| +24% | +$116K | 0.23% | 49 |
|
|
2019
Q4 | $512K | Buy |
5,787
+212
| +4% | +$17.6K | 0.17% | 56 |
|
|
2019
Q3 | $422K | Buy |
5,575
+835
| +18% | +$57.2K | 0.16% | 57 |
|
|
2019
Q2 | $345K | Buy |
4,740
+889
| +23% | +$69.9K | 0.13% | 68 |
|
|
2019
Q1 | $310K | Buy |
3,851
+32
| +0.8% | +$2.62K | 0.12% | 68 |
|
|
2018
Q4 | $352K | Buy |
3,819
+243
| +7% | +$21.4K | 0.13% | 63 |
|
|
2018
Q3 | $338K | Buy |
3,576
+506
| +16% | +$48K | 0.13% | 68 |
|
|
2018
Q2 | $284K | Buy |
3,070
+5
| +0.2% | +$488 | 0.12% | 66 |
|
|
2018
Q1 | $290K | Buy |
3,065
+199
| +7% | +$21.9K | 0.13% | 61 |
|
|
2017
Q4 | $277K | Buy |
2,866
+16
| +0.6% | +$1.51K | 0.12% | 66 |
|
|
2017
Q3 | $253K | Buy |
2,850
+21
| +0.7% | +$1.6K | 0.11% | 69 |
|
|
2017
Q2 | $205K | Buy |
+2,829
| New | +$190K | 0.09% | 77 |
|
Other funds holding ABBV
BSW Wealth Partners's ABBV Position: Q2 2026 in Review
BSW Wealth Partners reduced its AbbVie (ABBV) stake by 0.69% in Q2 2026, selling an estimated $15.5K and leaving 10,424 shares worth $2.62M. The position accounts for 0.29% of the portfolio, ranked #53.
BSW Wealth Partners first reported a position in ABBV in Q2 2017 and has held it in 37 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- BSW Wealth Partners held 10,424 shares of AbbVie worth $2.62M as of Q2 2026.
- BSW Wealth Partners sold 72 AbbVie shares in Q2 2026, an estimated $15.5K.
- AbbVie made up 0.29% of BSW Wealth Partners's portfolio in Q2 2026, its #53 holding.
- BSW Wealth Partners first reported a position in AbbVie in Q2 2017 and has held it in 37 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.